Učitavanje...
Anti-angiogenic therapy for ovarian cancer
Angiogenesis is a known hallmark in cancer and plays a crucial role in ovarian cancer carcinogenesis and invasion. Anti- angiogenic agents are active in ovarian cancer treatment either as monotherapy or combined with chemotherapy, immunotherapy or poly ADP ribose polymerase (PARP) inhibitors. We rev...
Spremljeno u:
| Izdano u: | EJC Suppl |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7573465/ https://ncbi.nlm.nih.gov/pubmed/33240446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejcsup.2020.02.003 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|